Seeking Alpha

Molecular diagnostics firm Cepheid (CPHD) up 6% AH as it gets FDA clearance for a test that...

Molecular diagnostics firm Cepheid (CPHD) up 6% AH as it gets FDA clearance for a test that detects genetic variations related to an increased risk of blood clots. (PR)
From other sites
Comments (1)
  • ray b
    , contributor
    Comments (205) | Send Message
     
    Not much activity for good news
    24 Sep 2009, 05:15 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs